Riparin A, a compound from Aniba riparia, attenuate the inflammatory response by modulation of neutrophil migration

Chem Biol Interact. 2015 Mar 5:229:55-63. doi: 10.1016/j.cbi.2015.01.029. Epub 2015 Feb 3.

Abstract

Inflammation is a local tissue response to attacks characterized by vascular and cellular events, including intense oxidative stress. Riparin A, a compound obtained from Aniba riparia, has been shown to have antioxidant activity and cytotoxicity in vitro. This study was aimed at evaluating the anti-inflammatory effect of riparin A against acute inflammation. The results of our evaluations in various experimental models indicated that riparin A reduced paw edema induced by carrageenan, compound 48/80, histamine, and serotonin. Furthermore, it decreased leukocyte and neutrophil counts, myeloperoxidase activity, thiobarbituric acid reactive substance (TBARS) levels, and cytokine (tumor necrosis factor-α and interleukin-1β) levels increased by carrageenan-induced peritonitis, and reversed glutathione levels. Riparin A also reduced carrageenan-induced adhesion and rolling of leukocytes on epithelial cells and did not produce gastric-damage as compared with indomethacin. In conclusion, the data show that riparin A reduces inflammatory response by inhibiting vascular and cellular events, modulating neutrophil migration, inhibiting proinflammatory cytokine production, and reducing oxidative stress.

Keywords: Inflammation; Neutrophil; Oxidative stress; Riparin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / isolation & purification
  • Anti-Inflammatory Agents / therapeutic use*
  • Antioxidants / isolation & purification
  • Antioxidants / therapeutic use
  • Benzamides / isolation & purification
  • Benzamides / therapeutic use*
  • Carrageenan / adverse effects*
  • Carrageenan / immunology
  • Cell Adhesion / drug effects
  • Cytokines / immunology
  • Edema / chemically induced
  • Edema / drug therapy*
  • Edema / immunology
  • Edema / pathology
  • Extremities / pathology
  • Immune System Diseases / chemically induced
  • Immune System Diseases / drug therapy*
  • Immune System Diseases / immunology
  • Immune System Diseases / pathology
  • Inflammation / chemically induced
  • Inflammation / drug therapy
  • Inflammation / immunology
  • Inflammation / pathology
  • Lauraceae / chemistry
  • Leukocyte Disorders / chemically induced
  • Leukocyte Disorders / drug therapy*
  • Leukocyte Disorders / immunology
  • Leukocyte Disorders / pathology
  • Leukocyte Rolling / drug effects
  • Male
  • Mice
  • Neutrophils / drug effects*
  • Neutrophils / immunology
  • Neutrophils / pathology
  • Oxidative Stress / drug effects
  • Peritonitis / chemically induced
  • Peritonitis / drug therapy*
  • Peritonitis / immunology
  • Peritonitis / pathology
  • Peroxidase / immunology
  • Phenethylamines / isolation & purification
  • Phenethylamines / therapeutic use*

Substances

  • Anti-Inflammatory Agents
  • Antioxidants
  • Benzamides
  • Cytokines
  • N-phenethylbenzamide
  • Phenethylamines
  • Carrageenan
  • Peroxidase

Supplementary concepts

  • Neutrophil Chemotactic Response, Abnormal